Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?
- 1 December 2001
- journal article
- review article
- Published by Elsevier BV in Trends in Parasitology
- Vol. 17 (12), 582-588
- https://doi.org/10.1016/s1471-4922(01)02085-2
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Using evidence to change antimalarial drug policy in KenyaTropical Medicine & International Health, 2000
- The mechanism of resistance to sulfa drugs in Plasmodium falciparumDrug Resistance Updates, 1999
- Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from TanzaniaTropical Medicine & International Health, 1998
- Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan AfricaTropical Medicine & International Health, 1998
- A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistanceParasitology, 1997
- Drug-resistant Malaria: Laboratory and Field InvestigationsJournal of Pharmacy and Pharmacology, 1997
- Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparumMolecular and Biochemical Parasitology, 1997
- Sequence Variation of the Hydroxymethyldihydropterin Pyrophosphokinase: Dihydropteroate Synthase Gene in Lines of the Human Malaria Parasite, Plasmodium falciparum, with Differing Resistance to SulfadoxineEuropean Journal of Biochemistry, 1994
- Antimalarial drug resistance: the pace quickensJournal of Antimicrobial Chemotherapy, 1992
- The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasitesPharmacology & Therapeutics, 1990